Meet the Equation

Why It Matters

Embedding race into kidney‑function equations skews care for Black patients, delaying life‑saving treatments and perpetuating health inequities; eliminating the correction is essential for fair, evidence‑based medicine.

Key Takeaways

• Race-adjusted eGFR equation inflates kidney function for Black patients.
• Inflated scores delay transplant eligibility, worsening patient outcomes.
• Original study relied on flawed, small-sample assumptions about muscle mass.
• Physicians and trainees now challenge race-based algorithms as racist.
• Removing race correction could improve equity in kidney care.

Summary

The video investigates how a race‑adjusted eGFR (estimated glomerular filtration rate) formula, introduced in the late 1990s, has systematically over‑estimated kidney function for Black patients, affecting diagnosis and treatment decisions. It traces the origin of the correction factor to a 1999 study that linked higher creatinine levels to presumed greater muscle mass in African‑American individuals, despite limited data and the social construction of race. Key data points include the dual eGFR scores shown to Esther Daly—one higher African‑American value and a lower non‑Black value— and the finding that a 4% difference can keep a Black patient below the 20% threshold needed for transplant listing. The algorithm’s bias has delayed dialysis or transplant referrals for many, while white patients with identical lab values qualify earlier. Personal narratives underscore the impact: Esther Daly’s late‑stage kidney disease, Dr. Vanessa Grubs’ patient who was denied a transplant until she bypassed the race‑adjusted formula, and medical students at Harvard who publicly questioned the science. Experts like Dr. Martha Pavlakis and Dr. Andrew Levy explain the original rationale, while critics highlight the flawed evidence and the ethical concerns of embedding race into clinical decision‑making. The story signals a broader reckoning in medicine: removing race from eGFR calculations could accelerate equitable access to transplants, dialysis, and other interventions, prompting hospitals, labs, and guideline committees to revise standards and address systemic bias in diagnostic tools.

Original Description

Many clinical algorithms, including the eGFR test for kidney function, have actually had race baked into them and produce different results for Black patients. Most of us assume these algorithms are based on science, but what if the science is wrong?

A full transcript of this episode is available at https://www.nejm.org/doi/full/10.1056/NEJMp2601974.